These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6495325)

  • 1. Rapid radioimmunoassay of plasma GH and its application to the judgement of surgical results in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Shimizu Y; Murakami O; Ikeda H; Katakura R; Niizuma H; Suzuki J; Yoshinaga K
    Tohoku J Exp Med; 1984 Aug; 143(4):467-71. PubMed ID: 6495325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma growth hormone responses to sulpiride in patients with acromegaly.
    Hanew K; Sato S; Sasaki A; Kasai M; Shimizu Y; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Apr; 142(4):445-52. PubMed ID: 6429896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative studies of growth hormone secretion in acromegaly after isolated and combined application of insulin hypoglycemia, LH-RH- and TRH tests (author's transl)].
    Schneider KR; Müller G; Wiegelmann W; Solbach HG; Krüskemper HL
    Klin Wochenschr; 1978 May; 56(9):461-7. PubMed ID: 349258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decrease in human growth hormone (HGH) levels during transsphenoidal surgery for acromegaly as a guide for prognosis.
    Yamada S; Shishiba Y; Kitano M; Seki Y; Umezu H; Umezu Y; Ohtsuki N; Yamazaki Y; Aiba T
    Endocrinol Jpn; 1985 Dec; 32(6):899-906. PubMed ID: 3833531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolactin concentrations in patients with acromegaly: clinical significance and response to surgery.
    Franks S; Jacobs HS; Nabarro JD
    Clin Endocrinol (Oxf); 1976 Jan; 5(1):63-9. PubMed ID: 813917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Size heterogeneity of circulating growth hormone in acromegaly. "Big-big" GH forms are associated with inappropriately low IGF-I levels.
    Arosio M; Nissim M; Ballabio M; Orefice R; Bazzoni N; Faglia G
    Acta Endocrinol (Copenh); 1991 Aug; 125(2):150-9. PubMed ID: 1897332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A prospective analysis of 151 cases of patients with acromegaly operated by one neurosurgeon: a follow-up of more than 23 years.
    Abbassioun K; Amirjamshidi M; Mehrazin A; Khalatbary I; Keynama M; Bokai H; Abdollahi M
    Surg Neurol; 2006 Jul; 66(1):26-31; discussion 31. PubMed ID: 16793431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
    Losa M; Schopohl J; König A; Müller OA; von Werder K
    J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of acromegaly by transethmoidal hypophysectomy.
    Richards SH; Thomas JP
    Q J Med; 1980; 49(193):21-31. PubMed ID: 6254108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma growth hormone half-life after selective removal of adenoma in acromegalics determines the outcome of surgery.
    Roelfsema F; van der Heide D; Lowry PJ; van Dulken H; Schröder-van der Elst J
    Clin Endocrinol (Oxf); 1988 Jan; 28(1):51-9. PubMed ID: 2844444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly.
    Freda PU; Post KD; Powell JS; Wardlaw SL
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3808-16. PubMed ID: 9814451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent results of secondary transnasal surgery for residual or recurring acromegaly.
    Abe T; Lüdecke DK
    Neurosurgery; 1998 May; 42(5):1013-21; discussion 1021-2. PubMed ID: 9588545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of acromegaly in a diabetic cat with transsphenoidal hypophysectomy.
    Meij BP; Auriemma E; Grinwis G; Buijtels JJ; Kooistra HS
    J Feline Med Surg; 2010 May; 12(5):406-10. PubMed ID: 20417901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acromegaly.
    Scacchi M; Cavagnini F
    Pituitary; 2006; 9(4):297-303. PubMed ID: 17077948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for higher proportion of "little" growth hormone with increased radioreceptor activity in acromegalic plasma.
    Gorden P; Lesniak MA; Eastman R; Hendricks CM; Roth J
    J Clin Endocrinol Metab; 1976 Aug; 43(2):364-73. PubMed ID: 950368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatomedin C in treated acromegaly: poor correlation with growth hormone and clinical response.
    Stonesifer LD; Jordan RM; Kohler PO
    J Clin Endocrinol Metab; 1981 Nov; 53(5):931-4. PubMed ID: 7197287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma growth hormone profile in acromegaly before and ten days after transsphenoidal surgery.
    Edén S; Bengtsson BA; Albertsson-Wikland K; Elfversson J; Lindstedt G; Lundberg PA; Petruson B; Rosberg S
    Acta Endocrinol (Copenh); 1989 Jan; 120(1):113-20. PubMed ID: 2492135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transsphenoidal microsurgery in the treatment of acromegaly and gigantism.
    Arafah BU; Brodkey JS; Kaufman B; Velasco M; Manni A; Pearson OH
    J Clin Endocrinol Metab; 1980 Mar; 50(3):578-85. PubMed ID: 6244327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional treatment of acromegaly by transsphenoidal microsurgery.
    García-Uría J; del Pozo JM; Bravo G
    J Neurosurg; 1978 Jul; 49(1):36-40. PubMed ID: 660266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of acromegaly by transsphenoidal hypophysectomy with cryoapplication.
    Touliatos J; Lindholm BW
    Clin Endocrinol (Oxf); 1975 Jan; 4(1):53-64. PubMed ID: 1122655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.